Q3 2020 13F Holders as of 9/30/2020
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
67.6M
-
Number of holders
-
316
-
Total 13F shares, excl. options
-
54.6M
-
Shares change
-
-689K
-
Total reported value, excl. options
-
$6.2B
-
Value change
-
-$68.4M
-
Put/Call ratio
-
0.57
-
Number of buys
-
160
-
Number of sells
-
-145
-
Price
-
$113.50
Significant Holders of TANDEM DIABETES CARE INC - Common Stock, par value $0.001 per share (TNDM) as of Q3 2020
374 filings reported holding TNDM - TANDEM DIABETES CARE INC - Common Stock, par value $0.001 per share as of Q3 2020.
TANDEM DIABETES CARE INC - Common Stock, par value $0.001 per share (TNDM) has 316 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 54.6M shares
of 67.6M outstanding shares and own 80.78% of the company stock.
Largest 10 shareholders include FMR LLC (5.98M shares), VANGUARD GROUP INC (5.07M shares), WELLINGTON MANAGEMENT GROUP LLP (3.63M shares), BlackRock Inc. (3.43M shares), Invesco Ltd. (1.61M shares), Capital World Investors (1.55M shares), GILDER GAGNON HOWE & CO LLC (1.4M shares), FRED ALGER MANAGEMENT, LLC (1.39M shares), PRICE T ROWE ASSOCIATES INC /MD/ (1.33M shares), and FEDERATED HERMES, INC. (1.3M shares).
This table shows the top 316 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.